Recently, the use of gold nanoparticles as potential tumor selective radiosensitizers has been
proposed as a breakthrough in radiotherapy. Experiments in living cells and in vivo have …

AGuIX ® are sub-5 nm nanoparticles made of a polysiloxane matrix and gadolinium
chelates. This nanoparticle has been recently accepted in clinical trials in association with …

This roadmap outlines the potential roles of metallic nanoparticles (MNPs) in the field of
radiation therapy. MNPs made up of a wide range of materials (from Titanium, Z= 22, to Bismuth, …

β-Amyloid peptides (Aβ) that form the senile plaques of Alzheimer disease consist mainly of
40- and 42-amino acid (Aβ 40 and Aβ 42) peptides generated from the cleavage of the …

A new efficient type of gadolinium-based theranostic agent (AGuIX®) has recently been
developed for MRI-guided radiotherapy (RT). These new particles consist of a polysiloxane …

Enhancement of radiation effects by high-atomic number nanoparticles (NPs) has been
increasingly studied for its potential to improve radiotherapeutic efficacy. The underlying …

Nanomedicine is proposed as a novel strategy to improve the performance of radiotherapy.
High-Z nanoparticles are known to enhance the effects of ionizing radiation. Recently, …

Cancer radiation therapy with charged particle beams, called particle therapy, is a new
therapeutic treatment presenting major advantages when compared to conventional radiotherapy…

Recently, the addition of nanoparticles (NPs) has been proposed as a new strategy to
enhance the effect of radiotherapy particularly in the treatment of aggressive tumors such as …

Background Tumor targeting of radiotherapy represents a great challenge. The addition of
multimodal nanoparticles, such as 3 nm gadolinium-based nanoparticles (GdBNs), has been …